Antibody Level Predicts the Clinical Course of Breakthrough Infection of COVID-19 Caused by Delta and Omicron Variants: A Prospective Cross-Sectional Study.
Min Hyung KimYooju NamNak Hoon SonNamwoo HeoBongyoung KimEawha KangAreum ShinAndrew Jihoon YangYoon Soo ParkHeejung KimTaeyoung KyongYong Chan KimPublished in: Open forum infectious diseases (2022)
Antibody levels are predictive of the clinical course of COVID-19 in vaccinated patients with Delta and Omicron variant infections. Our data highlight the need for concentrated efforts to monitor patients with severe acute respiratory syndrome coronavirus 2 infection who are at risk of low antibody levels.